Inventor · disambiguated record
Kiran Musunuru
Also filed as: MUSUNURU KIRAN
2 granted patents·13 pending applications·110 citations·filing 2007–2023
69Inventor score
Files withHARVARD COLLEGE9UNIV PENNSYLVANIA3CHILDRENS HOSPITAL PHILADELPHIA1KATHIRESAN SEKAR1MUSUNURU KIRAN1
Top patents by PatentIndex Score
15 records- 0196US9822370B2Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAsHARVARD COLLEGE·Filed 2014·Granted Nov 21, 2017·98 cites·12 claims
- 0289US10208319B2Therapeutic uses of genome editing with CRISPR/Cas systemsHARVARD COLLEGE·Filed 2014·Granted Feb 19, 2019·12 cites·11 claims
- 0374US2022333119A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 0470US2021277423A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 0570US2021285015A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 0666US2025059567A1Compositions and methods for the management and treatment of phenylketonuriaUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0766US2021274726A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 0863US2018291383A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2017·Application pending·0 cites
- 0963US2025312485A1Compositions and methods for the management and treatment of phenylketonuriaUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1060US2015176013A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2014·Application pending·0 cites
- 1160US2020048659A1THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMSHARVARD COLLEGE·Filed 2019·Application pending·0 cites
- 1255US2009061402A1Methods And Systems For Providing Interactive Educational TrainingMUSUNURU KIRAN·Filed 2007·Application pending·0 cites
- 1346US2022275402A1Compositions and methods for in utero gene editing for monogenic lung diseaseCHILDRENS HOSPITAL PHILADELPHIA·Filed 2020·Application pending·0 cites
- 1445US2024075164A1In utero crispr-mediated therapeutic editing of genesUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 1528US2012289593A1Methods for risk assessment, treating, and diagnosing myocardial infarctionKATHIRESAN SEKAR·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kiran Musunuru files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →